- Investigate all reports of active or suspected cases of Tuberculosis
- Ensure required follow-up has been done on all reported positive TB skin tests
- Provide TB skin testing at our clinics
- Provide free TB medication for prophylaxis and treatment
- Provide information, advice on the management of LTBI and Active TB cases to healthcare providers
- Provide multilingual resources on TB
- Follow-up of persons under medical surveillance for Tuberculosis
Public Health TB clinics
- Offered one Thursday per month at our Guelph 160 Chancellors Way location
- Staffed by a respirologist and public health nurses
- We welcome written referrals from physicians and nurse practitioners. Please fax referrals to the Reportable Disease secure fax line at 1-855-WDG-LINE (1-855-934-5463).
Tuberculosis is a reportable disease under the Health Protection and Promotion Act - R.S.O. 1990, Chapter H.7.
All physicians, laboratories, institutions, hospital administrators, and schools must report all persons with any of the following to Public Health:
- Latent TB infection
- Suspected active TB
- Confirmed active TB
To report a positive Mantoux TB skin test result, use this form: Reporting Mantoux TB Skin Test (PDF).
Practice Guidelines and Resources
For detailed information on current and past BCG policies and practices for over 180 countries.
A useful tool to estimate the risk of active tuberculosis for person with TB skin tests of 5mm+.
Forms and fact sheets
Reporting and Screening:
- Reporting Mantoux TB Skin Test Form
- Tuberculosis: How to Assess New Residents, Employees, and Volunteers
- Recommendations for Tuberculosis Screening in Long-term Care and Retirement Home
TB Testing and Medication:
- The 4 R’s of the Tuberculin Skin Test
- The Tuberculosis Skin Test (poster)
- TB Skin Test (fact sheet)
- Two-Step TB Skin Test (fact sheet)
- BCG Information for Healthcare Professionals (fact sheet)
- Ethambutol (fact sheet)
- Isoniazid (fact sheet)
- Pyrazinamide (fact sheet)
- Rifampin (fact sheet)
- Collection of Sputum Samples (fact sheet)
TB Fact Sheets:
Interferon Gamma Release Assays (IGRA Testing)
Two Interferon Gamma Release Assays (IGRAs) are licensed for use in Canada:
- Quantiferon TB Gold (available through Gamma-Dynacare commercial laboratories)
- T-SPOT TB
These tests are not covered under the Ontario Health Insurance Plan (OHIP) and cost approximately $90 each.
For more information:
- Interferon-Gamma Release Assays (IGRAs) (fact sheet)
No additional resources found